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Abstract
Background
Access to prompt and effective treatment is the cornerstone for malaria control. Population
Services International in collaboration with the Ministry of Health launched a malaria behav-
iour change communication intervention in Nyanza province, Kenya. The initiative aimed to
improve: symptom recognition and prompt access to government health facilities for febrile
children; effective treatment with the recommended first-line drug artemether-lumefantrine
(AL) in public health facilities and adherence to the AL regimen.
Methods
Pre- and post-intervention cross-sectional household surveys were used to evaluate the
impact of the intervention on prompt and correct use of AL for febrile children below five
years of age. The primary outcome was the proportion of children below five years of age
with fever in the last 14 days accessing AL within 48 hours of fever onset.
Results
There was an increase from 62.8% pre-intervention to 79.4% post-intervention (95% CI:
11.1, 22.1) in caregivers who reported seeking formal treatment promptly (on the same day,
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or next day) for their febrile children. However, there was a decrease in the use of govern-
ment health facilities in the post-intervention period. There was a small increase in the
proportion of children accessing AL within 48 hours of fever onset [18.4% vs 23.5% (0.1–
10.0)].
Conclusion
The findings of this evaluation demonstrate that interventions that target only one sector
may have a limited impact on improvements in prompt and effective treatment where multi-
ple sources of treatments are sought for febrile illness. Additionally, the context in which an
intervention is implemented is likely to influence the process and outcomes.
Introduction
In September, 2008, the Roll Back Malaria (RBM) partnership launched the Global Malaria
Action Plan (GMAP) to provide a framework for action around which stakeholders in malaria
endemic nations could coordinate their malaria control efforts [1]. As part of this strategy pre-
elimination countries were expected to make sure that at least 80% of febrile children in
malaria endemic regions accessed effective antimalarial treatment early in their illness by 2015
[1]. By 2006 every country in sub-Saharan Africa had abandoned failing monotherapies in
favor of artemisinin-based combination therapy (ACT) as recommended first-line treatment
for uncomplicated malaria [2], but, despite these policy changes, recent data suggest that there
was a large variation in the proportion of children under five with a fever treated with an anti-
malarial who received an ACT ranging from under 5% in Chad to over 90% in Rwanda [3].
In Kenya, the first-line antimalarial drug policy was changed officially in 2004 from sulpha-
doxine-pyrimethamine (SP) to artmether-lumefantrine (AL) but it wasn’t until late 2006 that
AL was procured and distributed to all levels of the government and mission health sectors
alongside revised standard treatment guidelines and in-service training for health care provid-
ers [4]. Despite a few pilot interventions targeting retail-sector provision, AL remained a pre-
scription-only medicine and largely confined to formal public health services across Kenya [5]
through to the end of 2010. Cross-sectional health facility surveys undertaken in Kenya, four to
six months after AL policy roll out, reported that only 28% of children meeting the national
guidelines definition of uncomplicated malaria were prescribed AL, despite AL being in stock
on the day of the survey [6]. Even fewer children were receiving the effective antimalarial early
in their illness with studies undertaken at various sites in Kenya between 2006 and 2007,
reporting that only 11% of febrile children below 5 years received AL within 48 hours of fever
onset [7].
In an attempt to address the large gap between the GMAP targets and the proportion of
febrile children under five accessing AL from public sector services early in their illness in
Kenya, Population Services International (PSI) in collaboration with the Ministry of Public
Health and Sanitation (MoPHS) developed and implemented an intensive malaria case man-
agement behavioral change initiative. The initiative was undertaken during the previous
malaria treatment policy recommendations of presumptive treatment of all fevers in malaria
endemic regions of Kenya. This initiative began in February 2009 with financial support from
the Pfizer Mobilize against Malaria program [8] and identified two principal target popula-
tions: prescribers of anti-malarials operating from government health facilities and caretakers
of young children residing in the community. The impact of the intervention targeting
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prescribers (enhanced health worker training) has been reported elsewhere [9]. In this paper
we focus on the impact of the second aspect of the intervention, a community based behaviour
change communication campaign designed to improve the numbers of febrile children attend-
ing public health facilities promptly and increase the proportion completing the AL treatment
regime. The core theme of the behavioural change initiative was prompt action for all fevers in
children branded under the phrase haraka upesi (English = prompt action). A professional
advertising agency based in Nairobi was employed to work on communication messages, chan-
nels and materials following a communications brief provided by PSI that sought to reinforce
three key behaviours: 1) the importance of prompt symptom recognition specifically, getting
febrile children into clinics promptly, 2) effective treatment with the recommended first-line
dug (AL) at a public health facility and 3) adherence to the AL regimen. The channels of
communication included mass media (including radio), posters, distribution of messaging
materials, message dissemination through road-shows and established community-based orga-
nisations. Here we report on the evaluation of the impact of the intervention on the appropriate
treatment (time/drug/dose/duration) for children under five who had suffered from a fever in
the past two weeks. Community level intervention activities were undertaken between Novem-
ber 2009 and September 2010. Radio messaging was undertaken between October 2009 and
September 2010.
Methods
Study district
Bondo district was selected as the evaluation district from the twelve districts located in Nyanza
Province. Bondo is on the shores of Lake Victoria with intense, perennial malaria transmission
with a predicted 2009 parasite prevalence in children in excess of 40% [10], where hospital
admissions have not declined since 1999 [11], where previous studies have suggested that
access to prompt treatment with AL was poor following the change in drug policy [7] and per-
formance of health workers in the government sector sub-optimal with respect to managing
febrile children [6,12]. The district has four main administrative divisions namely: Bondo,
Usigu, Madiany and Rarieda. Forty one government and mission health facilities serve the dis-
trict population of over 280,000 inhabitants and are staffed by over 100 health workers.
Study design
The study was designed as a pre-post intervention cluster sample survey [13].
A GIS platform was developed including enumeration areas (EA) and associated population
data was created based on EAs used during the 1999 national census [14], roads, rivers, schools,
health facilities, market centres, administration offices and major landmarks created from
national digital data sources and updated through detailed mapping in July 2010. All data were
stored in ArcView GIS 3.2 (ESRI Inc., New York, USA) for survey work and estimation of
travel distances to health facilities, market centre’s and proximity to posters and CBO small
group sessions.
Sample size estimates for each of the household surveys were calculated for the proportion
of children who access effective malaria treatment within 48 hours of fever [15]. We assumed
an initial proportion of 11% of febrile children access AL within 48 hours on onset of symp-
toms (primary outcome) as described in 2007 in Bondo district [7] with a 4% minimum point
increase post-intervention. Included in the sample size estimation was an estimate of the pro-
portion of children aged less than five years, a 10% non-response rate and a design effect of 2
to adjust for clustering. The anticipated sample size was therefore computed as 600 households
located in 30 EA clusters. Two samples were selected, first for the pre-intervention survey and
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separately for the post-intervention survey. The second sample selection was increased to
accommodate an unexpectedly higher AL use at baseline and thus included 700 households
located in 35 clusters. Sample EAs were selected using the spatial randomization function in
ArcView 3.2 to ensure all areas across the district were equally represented. The distribution of
survey clusters is shown in Fig 1. Within each cluster, household were randomly selected using
the World Health Organization Expanded Programme of Immunization random walk [16,17].
Household surveys
Evaluation of community level intervention activities was undertaken through two cross-sec-
tional household surveys. Pre-intervention (baseline) household surveys were undertaken
between June and July 2009 and post-intervention surveys undertaken between July and
August 2010. Post-intervention surveys were delayed due to inadequate AL stocks in public
health facilities in Bondo between May and July 2010. All mothers or caretakers of children
aged under-five years were asked whether their child had experienced a fever in the last 14 days
and whether the child was febrile on the day of the survey. For each fever the sources, types
and timing of treatment actions were documented. A photo-illustrated guide was used to assist
recognition of proprietary forms of anti-malarials likely to be purchased from the retail sector
and those available in the public sector. Questions were also asked on numbers of tablets taken
and mothers were asked to show packaging if available to confirm completed doses. Finally
mother’s and caretakers were interviewed about their knowledge of malaria, AL and sources of
treatment and whether they had been exposed to any public messages on prompt fever treat-
ment and the source of these messages. A second photo-illustrated guide of all PSI community
Fig 1. The distribution of randomly selected pre- (Green) and Post-intervention (Pink) enumeration
area clusters for the household surveys. Blue clusters indicate where ten clusters were randomly selected
in both pre- and post-intervention selection
doi:10.1371/journal.pone.0130305.g001
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intervention materials was developed to enable mothers identify IEC materials distributed as
part of the intervention. The primary outcome was ‘the proportion of children under five years
of age with fever in the last 14 days accessing AL within 48 hours of fever onset’.
Adherence was examined among all fevers where treatment started four or more days pre-
ceding the survey day. A participant was defined as adherent if the caregivers presented an
empty AL blister pack and/or stated that all medicines had been administered. Non-adherents
were those who had leftover tablet (s) in a blister pack where treatment was started four days
and/or reported to have not completed the dose that they had been given. Caregivers who used
AL already existing in the household were excluded from the adherence analysis.
To establish whether caregivers adhered to AL treatment, questions were asked in the
household surveys on the total number of tablets given, those given in a single dose, number of
times per day a drug was given, number of days and whether all tablets were given. The number
of left over tablets was assessed by requesting to see incomplete AL blister packs (blister packs
with left over tablets) and, if not available, by calculating the total number of tablets adminis-
tered against the total number of tablets received.
Data were captured directly on data screens designed using Pendragon version 5.1 (Pendra-
gon Software Corporation, Libertyville, Illinois) with internal consistency checks, using per-
sonal digital assistants (model-HP Ipaq 114 classic handheld, Hewlett-Packard Company, Palo
Alto, California) and downloaded into Microsoft Office Excel (2007) comma separated value
(CSV) files.
Assessment of AL availability at government and mission health facilities
Data on drug availability was necessary to interpret the results from the pre- and post-interven-
tion community surveys. Inadequate AL supply at the point of care will inevitably result in
severely compromised malaria case management. Telephone interviews and physical audits
were undertaken with health facility in-charges in the universe of 36 government and five mis-
sion health facilities between January 2009 and June 2010 to assess AL availability.
Analysis
All analyses were performed using STATA, version 11 (StataCorp, College Station, Texas). A
household wealth index was constructed from household characteristics and asset data using
principal component analysis (PCA) [18,19]. Weights were derived from the first principal
component and used to construct the wealth index that classified households into wealth quin-
tiles, based on whether the household had electricity, radio, bicycle, mobile phone, household
head occupation status and level of education, household ownership of cows, main source of
drinking water, type of toilet facility, source of fuel for household cooking, household wall con-
struction material, and household floor material.
A descriptive analysis of fever treatment actions was first undertaken to obtain all frequency
distributions of relevant variables/indicators for pre-and post-intervention surveys. The analy-
sis accounted for the survey design by adjusting for cluster selection using svy command in
STATA. The survey design was self-weighting. The sample size and initial hypothesis was
based on the proportion of children with fever accessing AL within 48 hours, but the analysis
also assessed many different outcomes to assess the impact of the sensitization program. Differ-
ences in proportions were compared for significance using the chi-squared test, notably: 1)
changes in fever treatment seeking behaviour through a pre- versus post-intervention compari-
son; 2) access to antimalarial medicines by socio-economic quintile pre and post-intervention;
3) changes in the proportions of febrile children accessing AL at any time within 14 days, and a
subset within 48 hours of fever onset pre- and post-intervention; and 4) the changes in the
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proportions of febrile children accessing AL from public sector facilities within 48 (same day/
next day) of fever onset pre- and post-intervention. Logistic regression was used to determine
factors associated with prompt (within 48 hours) treatment of fever with AL among
children< 5 years of age in each of the surveys. The factors assessed included age of child,
child’s gender, caregiver’s age, caregivers’ level of education, number of children below five
years of age in the household, socio-economic status and distance to the nearest public health
facility. Associations were assessed using adjusted Wald test on the three outcomes. Variables
were screened using univariable analysis and those that gave a p value0.05 were considered
potential predictors of the treatment outcome. Univariate analysis of factors was performed
using logistic regression to take account of clustering. To decide which predictive factors to
include in the regression models the likelihood ratio test was used, and assessment of con-
founding and effect modification was considered only in factors that were associated with the
outcome (prompt treatment of fever). The test showed strong evidence (p<0.001) of variability
between clusters and between caregivers. Univariable and multivariable logistic regression
analysis with the child as the unit of analysis was undertaken using the random intercept
model (xtmelogit command) in STATA accounting for clustering at EA and caregiver levels.
Ethical Approval
Ethical approval for this study was obtained from the KEMRI National Ethical Review Com-
mittee (KEMRI SSC number: 1375) and the London School of Hygiene and Tropical Medicine
Ethics Committee (Ethical approval number: 5313).
Results
Children with fever
Of the 958 children under five years of age sampled in 2009, 506 (52.8%) were reported to have
experienced a fever event in the last 14 days. This was a higher proportion than in 2010 when
of the 1,123 children under five, 515 (45.9%) were reported to have had fever in the last 14 days
(p = 0.006) (Table 1). Of the children with reported fever, 81.8% and 73.2% in 2009 and 2010
respectively were not febrile on the day of the survey.
Fever treatment seeking behaviour pre- (2009) post- (2010) intervention
Table 2 shows the proportion of febrile children for whom any treatment was sought (includ-
ing home-medication with ‘western medicines’ but not including prayers, or use of herbal med-
icines) and those for whom any treatment was sought within 48 hours across the two surveys.
In both surveys most caregivers of febrile children reported seeking some form of treatment.
However, there was a increase from 87.3% in 2009 to 91.8% in 2010, in the proportion of febrile
children who sought any treatment (p = 0.02; Table 2). There was also an increase from 62.8%
in 2009 to 79.4% in 2010 (p<0.001; Table 2) in caregivers who reported seeking formal treat-
ment promptly (on the same day, or next day) for their febrile children. Sources of treatment
for fever were similar between observation periods, but the proportion of fevers where first
treatment actions included the formal public sector declined from 39.5% in 2009 to 22.3% in
2010 following the intervention (p =<0.001, Table 2). A decrease from 23.1% to 16.5% was
also observed in the proportion of febrile children accessing treatment from the public sector
within 48 hours (p = 0.04, Table 2) between the 2009 and 2010 surveys. There was little varia-
tion pre- and post-intervention in the proportions of caregivers first seeking treatment from
the retail sector (29.4%, in 2009 and 31.4% in 2010 or from private clinics (3.0%) in 2009 and
4.0% in 2010 (Table 2). There were, however, changes in the proportion of childhood fevers
Behaviour Change Communication and Fever Treatment Seeking Behaviour
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managed with drugs available within the household: from 12.4% in 2009 to 31.1% in 2010
(p =<0.001, Table 2). Community health workers were rarely accessed as the first source of
fever treatment in either 2009 or 2010.
Antimalarial treatments for febrile-children pre-post intervention
Of the 506 febrile children in the 2009 survey, the proportion accessing any antimalarial drug
in the last 14 days was 44.3%, similar to the 39.2% of the 515 febrile children who were reported
to have accessed antimalarial drugs during the 2010 survey (p = 0.13, Table 2). In addition,
there were no changes in the proportion of febrile children accessing AL at any time in the last
14 days between the two observation periods, 31.0% (2009) versus 32.0% (2010) (Table 2).
Table 1. Characteristics of surveyed communities, households, children and caregivers pre- and
post-intervention. Proportions are cluster adjusted.
Pre-intervention (June-
July 2009)
Post-intervention (July-
August 2010)
Number of clusters 30 35
Number of households 600 700
Number of children under ﬁve 958 1, 123
Number (%) children who were female 483 (50.4%) 558 (49.7%)
Number of children aged <1 year 204 (21.3%) 232 (20.7%)
Number of children aged 1 year 208 (21.7%) 202 (18.0)
Number of children aged  2 years 546 (57.0%) 689 (61.3)
Number of households with more than one
child < 5 years
293 (48.8) 355 (50.7)
Mean Euclidian distance (km) of household to
nearest public health facility (+/- SD)
2.6km (1.3) 2.3km (1.2)
Key household variables used for wealth
assets
Household head employed in wage economy 99 (16.5%) 88 (12.6%)
Household owner occupied 486 (81.0%) 629 (89.9%)
Source of drinking water—piped water 123 (20.5%) 138 (19.7%)
Source of drinking water—lake 224 (37.3%) 187 (26.7%)
Toilet = pit latrine 364 (60.7%) 417 (59.6%)
Household owns at least one bicycle 400 (66.7%) 483 (69.0%)
Household owns a radio 475 (79.2%) 553 (79.0%)
Household owns television 51 (8.5%) 86 (12.3%)
Household owns at least one mobile phone 384 (64.0%) 536 (76.6%)
Household connected to electricity 13 (2.2%) 5 (0.7%)
Household uses Firewood for cooking fuel 501 (83.5%) 621 (88.7%)
Household owns > = 10 cows 21 (3.5%) 34 (4.9%)
Household walls made from brick/cement 135 (22.5%) 115 (16.4%)
Household walls made from clay/mud 458 (76.3%) 579 (82.7%)
Household ﬂoor made from cement 145 (24.2%) 146 (20.9%)
Household ﬂoor made of earth 454 (75.7%) 553 (79.0%)
Household head education
Primary complete 407 (67.8%) 508 (72.6%)
Secondary or higher 168 (28.0%)
Number of caregivers interviewed 628 717
* Refers to households that own the structure/house in which they live in.
doi:10.1371/journal.pone.0130305.t001
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There was, however, a decline in the proportion of febrile children accessing amodiaquine
from 7.5% in 2009 to 1.7% in 2010 (p =<0.001, Table 2). Six percent (33) of febrile children in
Table 2. Caregivers first source of treatment seeking and antimalarials received for febrile children < 5 years of age.
Pre-intervention
(June-July 2009)
Post-intervention
(July-August 2010)
n (%) n (%) Difference in
proportions (95% CI)
P-
value*****
Fevers and source of treatment (First action)
Total Number of children <5 years of age 958 1,123
Proportion of children< 5 years reporting fever in last 14 days 506 (52.8) 515 (45.9) -6.9 (-11.1, -2.6) 0.006
Proportion of children< 5 years reporting fever in last 14 days
but not febrile on day of survey
414 (81.8) 377 (73.2) -8.6 (13.7, -3.5) 0.001
Number of children< 5 years reporting fever in last 14 days
but not febrile on day of survey
N = 506 N = 515
Proportion of all febrile children seeking any treatment (not
including prayers)
442 (87.3) 473 (91.8) 4.5 (0.7, 8.2) 0.02
Proportion of all febrile children seeking any treatment (not
including prayers) within 48 hours
318 (62.8) 409 (79.4) 16.6 (11.1, 22.1) <0.001
Proportion febrile children accessing treatment from formal
government of Kenya (GoK)/mission health facilities
200 (39.5)** 115 (22.3)** -17.2 (-22.8,-11.6) <0.001
Proportion febrile children accessing treatment from formal
government of Kenya (GoK)/mission health facilities within 48
hours
117 (23.1) 85 (16.5) -6.6 (-11.5, -1.7) 0.04
Proportion febrile children accessing treatment from formal
private sector
14 (3.0) 20 (4.0) 1.0 (-1.2, 3.2) 0.43
Proportion of febrile children accessing treatment from formal
retail sector
149 (29.4) 162 (31.4) 2.0 (-3.6, 7.6) 0.63
Proportion of febrile children accessing treatment from drugs
available in household
63 (12.4) 160 (31.1) 18.7 (13.8, 23.6) <0.001
Proportion of febrile children accessing treatment from
community health workers (CHWs)
16 (3.2) 16 (3.1) -0.1 (-2.2, 2.0) 1.00
Proportion of all febrile children not seeking any treatment 64 (12.7) 42 (8.2) -4.5 (-8.2, -0.7) 0.02
Drugs used to treat malaria
Proportion of febrile children accessing any anti-malarial drug
in last 14 days
224 (44.3) 202 (39.2) -5.1 (-11.1, 0.9) 0.12
Proportion of febrile children accessing AL at any time in last
14 days
157 (31.0)*** 165 (32.0)**** 1.0 (-4.7, 6.7) 0.76
Proportion of febrile children treated with quinine 33 (6.5) 27 (5.2) -1.3 (-4.2, 1.6) 0.44
Proportion of febrile children treated with sulfadoxine-
pyrimethamine (SP)
5 (1.0) 6 (1.3) 0.3 (-1.0, 1.6) 0.76
Proportion of febrile children treated with amodiaquine 38 (7.5)***** 9 (1.7) -5.8 (-8.3, -3.2) <0.001
Proportion of febrile children treated with chloroquine 3 (0.6) 1 (0.2) -0.4 (-1.2, 0.4) 0.30
Proportion of febrile children treated with dihydroartemisinin
+ piperaquine
1 (0.2) 0 -0.2 (-0.6, 0.2) -
*Proportions are cluster adjusted
**Range of proportion across clusters in 2009 (0–61.5%%); 2010 (0–83.3%)
***Includes 10 febrile children treated with quinine injections and AL;
****Includes 7 febrile children treated with quinine injections and AL
*****Includes one febrile child treated with amodiaquine and quinine injection
*****P-value from chi-squared test adjusted for clustering
doi:10.1371/journal.pone.0130305.t002
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2009 and 5.2% (27) in 2010 received quinine while a few of the febrile children received
ineffective and/or non-recommended monotherapies ineffective and/or non-recommended
monotherapies (Table 2). Across both surveys, only one child received dihydroartemisinin-
piperaquine, launched as the recommended second-line antimalarial in August 2010 (Table 2).
AL treatment, timing and adherence
For the primary indicator, ‘the proportion of children under five years of age with fever in the
last 14 days accessing AL within 48 hours of fever onset’ there was a 5.1 percentage point
increase from baseline 18.4% to 23.5% post-intervention (p = 0.06, Table 3). However, there
were no increases in the proportion of febrile children accessing AL from a public health facil-
ity within 48 hours of the onset of fever (Table 3). There was an increase in the numbers of
febrile children treated using AL available from within the household from 1.6% to 5.4%
between 2009 and 2010 (Table 3: 95% CI: 1.6, 6.0) but, since no data were collected on the orig-
inal source of the drugs which were used ‘from within the household’, it is not possible to iden-
tify where these drugs originally came from. Information on the source of drugs from outside
the household was collected and, although there were no increases in the proportion of febrile
children accessing the retail sector as the first source of fever treatment, there was a significant
increase in the proportion of febrile children whose fever treatment included AL obtained from
the retail sector. The proportion of febrile children who received treatment with AL that had
been sourced from the retail sector rose from 1.4% in 2009 to 4.0% in 2010) (p = 0.01, Table 3),
Table 3. Comparison of AL treatment, timing and adherence between pre- (2009) and post-intervention (2010). All proportions are cluster adjusted
Pre-intervention
(June-July 2009)
Post-intervention
(July-August 2010)
n/N (%) n/N (%) Difference in
proportion (95% CI)
P-
value**
Source of AL treatment
Public sector 137/506 (27.1) 108/515 (21.0) -6.1 (-11.3, -0.9) 0.07
Formal private sector 5/506 (1.0) 10/515 (1.9) 0.9 (-0.6, 2.4) 0.30
Retail commercial sector 7/506 (1.4) 19/515 (4.0) 2.6 (0.6, 4.6) 0.01
Drugs available in household 8/506 (1.6) 28/515 (5.4) 3.8 (1.6, 6.0) <0.001
AL treatments where treatment started  4 days ago 147/157 (93.6) 152/165 (92.1) -1.5 (-7.1, 1.4) 0.60
Of all AL treatments where treatment started  4 days ago
number who completed dose
101/147 (68.7) 127/152 (83.5) 14.8 (5.3, 24.3) 0.01
Timing and adherence of AL treatment
Proportion of febrile children accessing AL within 48 hours 93/506 (18.4)* 121/515 (23.5)* 5.1 (0.1, 10.0) 0.06
Proportion of fevers children AL within 48 hours from a public
health facility
80/506 (15.8) 70/515 (13.6)** -2.2 (-6.5, 2.1) 0.39
Of all AL treatments within 48 hours and where treatment started
> = 4 days ago number who completed dose
56/93 (60.2) 78/121 (64.5) 4.3 (-8.8, 17.4) 0.58
Of all AL treatments within 48 hours from a public health facility
and where treatment started  4 days ago number who
completed dose
54/80 (67.5) 57/70 (81.4) 13.9 (0.2, 27.6) 0.05
Proportion of caregivers who sourced AL from public sector who
had dose explained
128/137 (93.4) 101/108 (93.5) 0.1 (-6.2, 6.3) 0.98
*Range of proportion across clusters in 2009 (0–33.9%); 2010 (0–52.9%)
**P-value from chi-squared test adjusted for clustering
doi:10.1371/journal.pone.0130305.t003
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suggesting that AL was becoming more available in this sector and that caregivers were more
aware of AL and asked for it from the retail shops.
In 2009, 147 (93.6%) and in 2010, 152 (92.1%) of all AL treatments were started four or
more days prior to the survey day (Table 3). Of these, there was an increase in the proportion
who reported adhering to the complete course of AL treatment, from 68.7% in 2009 to 83.5%
in 2010 (p = 0.01, Table 3). Initiating treatment promptly was not associated with the likeli-
hood of dosage completion. Of all AL treatments that had been started within 48 hours of fever
onset and where the initial dose had been taken four or more days prior to the survey there was
no significant difference in the proportion of febrile children who were reported to have
received a complete course of treatment: 60.2% in 2009 and 64.5% in 2010 (p = 0.58, Table 3).
It is possible that the lack of change in adherence rates with increased promptness of treatment
was influenced by the higher rate of treatments sourced from within the home in 2010 since
these treatments were associated with high non-completion rates. Of the 28 febrile children in
the 2010 survey who were reported to have been given AL that was obtained from within the
household only nine (32.1%) reported that a complete course of drugs had been available at the
start of the treatment and that the full dose had been taken. When the analysis was restricted to
those where treatment was sought promptly at a public health facility, there was a significant
increase in adherence from 67.5% in 2009 to 81.4% in 2010 (p = 0.05, Table 3).
Predictors of fever treatment seeking behaviour and prompt access to
artemether-lumefantrine
In 2009, none of the variables were associated with prompt access to AL (Table 4). In 2010, uni-
variable logistic regression showed that children aged two years and above were four times
(p = 0.03, Table 5) more likely to access prompt fever treatment with AL compared with chil-
dren aged one year and below. Febrile children in less poor (quintile 4) households were three
times more likely to access AL within 48 hours of fever onset compared to those in poorer
quintiles (p = 0.05, Table 6). In the final regression model in 2010 only child’s age (p = 0.03,
Table 6) remained associated with prompt access to AL.
AL availability at government and mission health facilities
Over 70% of health facilities had any AL blister packs in stock across the two survey periods.
Between April and May 2010, less than half of health facilities had AL paediatric packs
(Table 7). Over 80% of health facilities had the adult AL blister packs (AL 24 tablets) in stock
during the audit period. At no point during the 10 months did all health facilities have all AL
blister packs in stock (Table 7). Less than half of health facilities had all AL blister packs in
stock two months prior to the pre- and post-intervention surveys. Furthermore, only 41.5%
and 19.5% of health facilities had all AL blister packs in April and May 2010. The study was
predicated on measuring access and use of AL from the public sector. Prior to each household
sample survey efforts were made to ensure adequate stocks of pediatric pack sizes were avail-
able at least four weeks before the survey began and during the survey period to ensure univer-
sal availability of AL at public health facilities. Two months prior to the post-intervention
survey, less than half of all facilities had AL paediatric packs in stock; however, we ensured that
AL was delivered to all health facilities in Bondo two weeks prior to the survey.
Discussion
The haraka upesi behaviour change communication intervention to improve prompt and effec-
tive treatment for children under five with a febrile illness targeted three steps on the fever
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Table 4. Univariable andmultivariable logistic regression analysis of factors predicting prompt (within 48 hours) treatment of fever with AL
among children < 5 years of age in 2009.
Univariable Multivariable
Variable No. of febrile
children
N (%) febrile children with
outcome
OR (95%
CI)
P
value
OR (95% CI) P
value
Child age
<1 yeara 90 18 (20.0) 1.0 1.0
1 year 118 17 (14.4) 0.5 (0.1,
1.6)
0.23 0.3 (0.1, 1.3) 0.11
 2 years 298 58 (19.5) 0.9 (0.3,
2.4)
0.83 0.8 (0.2, 2.5) 0.71
Child gender
Malea 246 39 (15.8) 1.0 1.0
Female 260 54 (20.8) 2.0 (0.9,
4.4)
0.10 2.5 (1.0, 6.5) 0.06
Caregiver level of education
No educationa 22 2 (9.1) 1.0 1.0
Complete primary school 383 64 (16.7) 1.3 (0.2,
9.9)
0.81 2.2 (0.1, 32.7) 0.58
Complete secondary or higher 101 27 (6.7) 5.2 (0.6,
47.1)
0.14 5.3 (0.3, 94.2) 0.26
Caregiver age
<20 yearsa 42 6 (14.3) 1.0 1.0
20–30 years 303 57 (18.8) 1.7 (0.4,
8.2)
0.47 1.2 (0.2, 8.1) 0.83
31–40 years 109 23 (21.1) 1.8 (0.3,
9.7)
0.49 1.0 (0.1, 7.7) 0.98
41–50 years 41 6 (14.6) 1.0 (0.1,
7.7)
0.99 0.5 (0.04, 6.7) 0.62
>50 years 11 1 (9.1) 0.5 (0.1,
14.1)
0.66 0.2 (0.002,
13.4)
0.43
Number of children under ﬁve years in
household
One childa 222 43 (19.4) 1.0 1.0
 two children 284 50 (17.6) 0.8 (0.4,
1.8)
0.67 0.6 (0.2, 1.7) 0.34
Socio-economic category of household
Quintile 1 (most poor)a 112 17 (15.2) 1.0 1.0
Quintile 2 (very poor) 86 21 (24.4) 3.4 (0.8,
13.6)
0.08 4.0 (0.8, 19.6) 0.08
Quintile 3 (poor) 106 24 (22.6) 2.9 (0.8,
10.9)
0.11 4.0 (0.9, 18.5) 0.08
Quintile 4 (less poor) 99 16 (16.2) 1.3 (0.3,
4.9)
0.70 1.0 (0.2, 5.1) 0.94
Quintile 5 (least poor) 103 15 (14.6) 1.1 (0.3,
4.0)
0.91 0.7 (0.1, 3.5) 0.68
Distance to nearest public health facility
<1 kma 72 15 (20.8) 1.0 1.0
1-<2km 96 15 (15.6) 0.6 (0.1,
2.6)
0.53 0.6 (0.1, 3.1) 0.54
2-<3km 144 26 (18.1) 0.8 (0.2,
3.0)
0.78 0.7 (0.1, 3.1) 0.63
(Continued)
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treatment seeking pathway: 1) prompt fever treatment, 2) fever treatment at a public health
facility and 3) adherence to the AL treatment regimen.
Overall, there were improvements in two key steps: prompt fever treatment and prompt
access to AL, with a 5.1 percentage point increase observed in the primary outcome. In Bondo
district, the majority of caregivers of children under five years of age with a fever sought treat-
ment for their child both before the implementation of the intervention in 2009 (87.3%) as well
as post intervention in 2010 (91.8%). There was a significant increase in prompt (within 48
hours) treatment seeking between 2009 and 2010 but this did not translate into increased
access to anti-malarial treatment, with only approximately 40% of fevers (44.3% in 2009 and
39.2% in 2010) receiving any anti-malarial. However, the proportion of febrile children access-
ing AL (32%) and accessing AL promptly (23%) in the post intervention period appears to be
relatively high when compared to reports from earlier surveys on treatment seeking behaviour
undertaken in Bondo district and in Kenya. The study by Gitonga and colleagues conducted in
Bondo district between 2006 and 2007 found that only 11% of caregivers with a febrile child
under 5 had accessed AL within 48 hours of fever onset [7]. It is possible that these differences
are related to the short time that had elapsed between the implementation of the AL policy and
the conduct of these surveys.
Data from the most recent World Malaria Report shows that the proportion of febrile chil-
dren accessing antimalarials in SSA ranges from 5.7% to 70% [20] and in most countries fewer
than 20% of febrile children access ACTs promptly [21]. Despite interventions aimed at
increasing prompt AL treatment in Bondo considerable efforts are required, as elsewhere in
Africa, to reach the the RBM target of 80%.
In Bondo, the proportion of febrile children whose caregivers reported using the govern-
ment sector as the first source for fever treatment declined despite the focus of the communica-
tion initiative being around prompt fever treatment at a public health facility. A recent
multicountry study found that only 13.4% of febrile children in Benin, 16% in Uganda and the
Democratic Republic of Congo (DRC), and 17.6% in Nigeria had been taken for treatment in a
public health facility [22]. Low use of government health facilities is not universal, however,
and a study undertaken in Zambia reported almost half (49.8%) of febrile children accessed a
public health facility for fever treatment [22], while public health facility utilization of50%
for fever treatment has been reported in Tanzania, Namibia, Mozambique, Djibouti, Sudan
and Liberia [23]. A study undertaken in Tanzania following the roll out an intervention similar
to haraka upesi reported that more half (58%) of febrile children accessed a health facility as
the first source for fever treatment, however, general health facility attendance among children
was already high (76%) at baseline [24]. In general, in Kenya the reported use of the
Table 4. (Continued)
Univariable Multivariable
Variable No. of febrile
children
N (%) febrile children with
outcome
OR (95%
CI)
P
value
OR (95% CI) P
value
3-<4km 116 25 (21.5) 1.2 (0.3,
4.4)
0.81 1.4 (0.3, 6.9) 0.65
4-<5km 63 9 (14.3) 0.4 (0.1,
2.3)
0.34 0.4 (0.1, 2.7) 0.35
5km 15 3 (20.0) 1.3 (0.1,
15.6)
0.84 2.8 (0.1, 54.4) 0.50
a Reference group
doi:10.1371/journal.pone.0130305.t004
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Table 5. Univariable andmultivariable logistic regression analysis of factors predicting prompt (within 48 hours) treatment of fever with AL
among children < 5 years of age in 2010.
Univariable Multivariable
Variable No. of febrile
children
N (%) febrile children with
outcome
OR (95%
CI)
p-
value
OR (95% CI) p-
value
Child age
<1 yeara 90 15 (17.0) 1.0 1.0
1 year 105 19 (18.5) 1.4 (0.3,
5.7)
0.63 1.5 (0.3, 7.0) 0.56
 2 years 320 87 (27.2) 4.5 (1.2,
17.4)
0.03 5.5 (1.3,
22.9)
0.02
Child gender
Malea 257 61 (23.7) 1.0 1.0
Female 258 60 (23.3) 0.9 (0.4,
1.9)
0.83 0.8 (0.3, 1.9) 0.65
Caregiver level of education
No educationa 10 0 (-)
Complete primary school 425 95 (22.3) 1.0 1.0
Complete secondary or higher 80 26 (32.5) 2.4 (0.8,
6.8)
0.10 2.2 (0.6, 7.9) 0.20
Caregiver age
<20 yearsa 43 7 (16.3) 1.0 1.0
20–30 years 307 80 (26.1) 2.9 (0.6,
13.8)
0.18 2.2 (0.3,
13.6)
0.40
31–40 years 111 21 (18.9) 1.4 (0.3,
7.5)
0.67 0.7 (0.1, 5.5) 0.79
41–50 years 41 9 (21.9) 1.9 (0.3,
13.7)
0.53 1.5 (0.1,
16.1)
0.72
>50 years 13 4 (31.0) 4.7 (0.3,
71.8)
0.26 4.3 (0.1,
115.6)
0.39
Number of children under ﬁve years in
household
One childa 210 53 (25.2) 1.0 1.0
 two children 305 68 (22.3) 0.8 (0.4,
1.8)
0.63 1.0 (0.4, 2.6) 0.98
Socio-economic category of household
Quintile 1 (most poor)a 117 23 (20.0) 1.0 1.0
Quintile 2 (very poor) 105 13 (12.4) 0.4 (0.1,
1.7)
0.24 0.3 (0.1, 1.5) 0.15
Quintile 3 (poor) 117 29 (25.0) 2.0 (0.6,
6.7)
0.25 1.5 (0.4, 5.9) 0.56
Quintile 4 (less poor) 98 32 (32.6) 3.5 (1.0,
12.3)
0.05 2.7 (0.6,
11.9)
0.19
Quintile 5 (least poor) 78 24 (31.0) 3.2 (0.8,
12.3)
0.08 1.8 (0.4, 8.6) 0.43
Distance to nearest public health facility
<1 kma 37 11 (29.7) 1.0 1.0
1-<2km 217 48 (22.1) 0.5 (0.1,
2.2)
0.36 0.3 (0.1, 1.9) 0.20
2-<3km 123 31 (25.2) 0.7 (0.1,
3.2)
0.61 0.4 (0.1, 2.9) 0.40
3-<4km 68 16 (23.5) 0.4 (0.1,
2.4)
0.31 0.2 (0.02,
1.9)
0.16
(Continued)
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government sector as the first source of treatment for febrile children ranges from 29.3% to
33.6% [23,25], lower than in Tanzania. In the current study undertaken in Bondo district
Kenya, at baseline in 2009, 39.5% of the caregivers reported that their first treatment action for
a febrile child was to take them to a government health facility and this dropped to 22.3% in
2010.
A key factor that has been found to influence treatment seeking behaviour for a febrile ill-
ness is the availability of drugs [24, 25–29]. Understandably, most caregivers will seek treat-
ment from sources where they are sure of receiving treatment with a drug. Nationwide stock
outs of AL at public health facilities were reported at the onset of this study between 2008 and
2009 and AL availability was variable throughout the entire study period. The political situa-
tion in Kenya at the onset of the study and delays in AL procurement affected AL supply in
Bondo district. Supply side problems in the public sector have been widely document as a key
factor affecting its use [27, 30–32]. It therefore seems likely that fluctuations in AL supply
might have led to a lack of patient confidence in our study population in the public sector’s
ability to provide treatment for fever which contributed to the drop off in use of government
health facilities as the first source of treatment that was observed in the post-intervention
period.
A more surprising observation was the increase between 2009 and 2010 in the number of
reports of first treatments of a febrile child being undertaken with drugs sourced from within
the household. It is possible that, in response to the fluctuations in AL supply mentioned previ-
ously, caregivers had become inclined to hoard AL packs in the household leading to the
observed increase in the proportion of home treatments (and home treatment with AL) in the
post-intervention survey. Of concern is the fact that only one third of the AL treatments
sourced from within the home were reported to have started with complete blisters packs while
two thirds of AL drugs obtained within the households were incomplete packs. The presence of
incomplete AL packs in the household and their use in subsequent febrile episodes has
Table 5. (Continued)
Univariable Multivariable
Variable No. of febrile
children
N (%) febrile children with
outcome
OR (95%
CI)
p-
value
OR (95% CI) p-
value
4-<5km 54 13 (24.1) 0.6 (0.1,
3.6)
0.59 0.3 (0.03,
2.6)
0.27
5km 16 2 (12.5) 0.2 (0.1,
3.2)
0.23 0.1 (0.002,
1.7)
0.10
a Reference group
doi:10.1371/journal.pone.0130305.t005
Table 6. Final multivariable regression of factors predicting prompt (within 48 hours) treatment of
fever with AL among children < 5 years of age in 2010- (factors with p-value <0.05).
Variable OR (95% CI) p-value
Child age
<1 yeara 1.0
1 year 1.4 (0.3, 6.0) 0.63
 2 years 4.6 (1.2, 18.2) 0.03
a Reference group
doi:10.1371/journal.pone.0130305.t006
Behaviour Change Communication and Fever Treatment Seeking Behaviour
PLOS ONE | DOI:10.1371/journal.pone.0130305 July 2, 2015 14 / 19
implications for correct dosing as it suggests that febrile children are receiving inadequate
doses. AL is taken over a three-day period and has a complex dosage scheduled. Several studies
have reported varying adherence rates for ACTs of between 38.7% and 93% [33–45] and poor
adherence to AL has been suggested as a major constraint to its effectiveness [37, 44, 46]. In the
current study reported adherence to AL increased from around two thirds (67%) to over 80%
among caregivers who sourced their treatment from the public health facility but this increase
was not reflected in overall adherence rates, perhaps due to the decline in the use of the govern-
ment sector.
The evaluation design included a post-intervention comparison to measure changes in the
fever treatment seeking indicators. We made adjustments for multiple comparisons using the
Bonferroni procedure [0.001 (0.05/34)]. However, the analyses presented in this study, do not
allow the attribution of any of the observed changes in the primary and secondary indicators to
reported exposure to the intervention. That is, the analysis provides an adequacy inference
with no attempt to attribute the observed changes to the haraka upesi intervention.
The Intervention reported in this study was a complex intervention implemented under
routine operational conditions. Such interventions present particular problems for evaluators,
as they contain several interacting components, they often involve a number of different behav-
iours and they tend targets different levels within a system (for example household and health
facility). In addition to the complexity of the intervention, a key strategy in the BCC campaign
Table 7. AL availability (all AL pack sizes) assessed by telephone interviews with health facilities (TI) or directs observation through physical audit
(PA) at 33 government facilities in 2009 and 41 government andmission facilities in 2010 in Bondo district. Note: Emergency supplies sent on 22nd
July 2010 to facilitate survey. AL 18 tablets (25-<35kgs) blister packs were not available for this emergency supply. In June and July 2010, six and twelve blis-
ter packs were Coartem Dispersible;
Number of
health facilities
Any AL blister
packs in stock
AL 6 tablets
blister pack in
stock
AL 12 tablets
blister pack in
stock
AL 18 tablets
blister pack in
stock
AL 24 tablets
blister pack in
stock
All AL blister
packs in stock
N n (%) n (%) n (%) n (%) n (%) n (%)
January
2009 (TI)
33 25 (75.8) 16 (48.5) 22 (66.7) 15 (45.4) 19 (57.6) 10 (30.3)
May 2009
(TI)
33 33 (100) 14 (42.4) 33 (100) 15 (45.4) 33 (100) 14 (42.4)
June 2009
(PA)
33 33 (100) 33 (100) 33 (100) 31 (93.9) 33 (100) 31 (93.9)
October
2009 (TI)
33 31 (93.9) 31 (93.9) 31 (93.9) 31 (93.9) 30 (90.9) 30 (90.9)
January
2010 (TI)*
41 40 (97.6) 27 (65.8) 37 (90.2) 37 (90.2) 37 (90.2) 24 (58.5)
April 2010
(TI)*
41 38 (93.0) 19 (46.3) 25 (61.0) 29 (70.7) 37 (90.2) 17 (41.5)
May 2010
(TI)*
41 32(78.0) 13(31.7) 18(43.9) 17(41.5) 33(80.5) 8(19.5)
June 2010
(TI)*
41 37 (95.0) 35 (89.7) 35 (89.7) 34 (87.2) 36 (92.3) 33 (84.6)
July 2010
(PA)*
41 41 (100) 41 (100) 41 (100) 18 (43.9) 41 (100) 18 (43.9)
August
2010 (PA)*
41 39 (95.1) 39 (95.1) 38 (93.0) 10 (24.4) 37 (90.2) 10 (24.4)
*Includes three new government health facilities established and commissioned in January 2010 through the Constituency Development Fund (CDF)
initiative and ﬁve mission health facilities
doi:10.1371/journal.pone.0130305.t007
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was the use of mass media (radio). Where mass media are employed it is difficult to identify an
appropriate control group that is not exposed to the intervention. Under these conditions it
was not possible to employ a probability evaluation. In this evaluation we undertook a process
evaluation to explore the way in which the intervention had been implemented and outcome
data in this study was collected using pre- and post-cross-sectional community surveys to
assess changes in caregiver treatment seeking behaviour. Overall, the evaluation cannot
completely isolate the effect of the haraka upesi intervention In this evaluation we undertook a
process evaluation to explore the way in which the intervention had been implemented and
outcome data in this study was collected using pre- and post-cross-sectional from those of
other concurrent processes or activities. Furthermore, the use of pre- and post-intervention
evaluation design does not account for the changes that occurred between the two time points
that were not related to the intervention. The time interval between intervention implementa-
tion and evaluation has been has also been highlighted as a methodological challenge in the
evaluation of BCC (www.cpc.unc.edu/measure/prh/rhindictators/crosscutting/bcc accessed 25/
07/2013).
Conclusion
Overall the data suggest that, during the pre- and post-intervention period the biggest barrier
to effective treatment for febrile children under five in Bondo district was the infrequent use of
the government health facilities as the first step in treatment seeking. There was evidence of a
significant shift in treatment seeking behaviour away from the government sector (the inter-
vention target delivery point) and the likely reasons for the shift in source of treatment relates
to the implementation context mentioned above (drug stock-outs) which lay outside of the
control of the intervention. These data demonstrate the importance of understanding the
implementation context when analysing and interpreting intervention outcomes. The context
may be the driver of how and whether the intervention works. They also demonstrate that in
contexts where treatment for febrile illnesses is available from more than one sector, interven-
tions that target only one sector will struggle to produce population level improvements in
prompt and effective treatment. To make a real impact upon effective case management of
febrile children at the national level, cross-sectoral interventions are needed. These are inter-
ventions across the potential sources of fever treatment and include public and mission, private
and retail sectors.
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